Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Aspira Women's Health Inc. (AWHL) vs XWELL, Inc. (XWEL)

Aspira Women's Health Inc. and XWELL, Inc. are both Diagnostics & Research companies. XWELL, Inc. is the larger, with a market value of $7.6M against $2.4M — 3.1× the size. XWELL, Inc. grew revenue faster over the last twelve months: −7.58% against −8.00%. Aspira Women's Health Inc. has the higher net margin (−117.1% vs −117.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, XWELL, Inc. leads on 9 and Aspira Women's Health Inc. on 7.

Valuation

Metric AWHL XWEL Diagnostics & Research median
P/E n/m n/m 33.95
P/S 1.35 0.27 4.87
P/B n/m 0.92 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m n/m 25.20
EV/Sales 1.52 0.30 5.66
Earnings yield (93.85%) (597.75%) (1.75%)
Free cash flow yield (41.10%) (178.41%) (0.13%)

Profitability

Metric AWHL XWEL Diagnostics & Research median
Gross margin 58.78% 34.34% 50.89%
Operating margin (80.75%) (61.31%) (8.57%)
Net margin (117.07%) (117.83%) (6.37%)
Free cash flow margin (55.32%) (47.65%) 0.00%
Return on equity 201.29% (557.21%) (2.92%)
Return on assets (213.58%) (155.10%) (6.71%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AWHL XWEL Diagnostics & Research median
Revenue growth (TTM) (8.00%) (7.58%) 7.69%
EPS growth (last fiscal year) 60.22% (38.80%) —
Revenue growth, 5-year CAGR 14.66% 28.35% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AWHL XWEL Diagnostics & Research median
Debt to equity (0.27) 0.00 0.11
Current ratio 0.52 2.27 2.02
Net debt to EBITDA 0.00 (0.08) 0.78

Dividend

Metric AWHL XWEL Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric AWHL XWEL Diagnostics & Research median
Market cap 2.44m 7.64m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack